While the activation of STAT3 is usually transient under normal conditions, STAT3 activation tends to become more persistent in a number of hematopoietic malignancies, such as multiple myeloma, melanoma, ovarian cancer, as well as prostate cancer [31]. This evidence concerns the gene STAT3 and melanoma.